Roger M. Klein - 06 Nov 2025 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
10%+ Owner
Signature
/s/ Roger Klein
Issuer symbol
EVOK
Transactions as of
06 Nov 2025
Net transactions value
-$95,885
Form type
4
Filing time
07 Nov 2025, 16:58:59 UTC
Previous filing
06 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klein Roger M. 10%+ Owner C/O CHOATE, HALL & STEWART, TWO INTERNATIONAL PLACE, BOSTON /s/ Roger Klein 07 Nov 2025 0001651175

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVOK Common Stock Sale $53,285 -5,000 -15% $10.66 29,000 06 Nov 2025 By IRA F1, F2
transaction EVOK Common Stock Sale $42,600 -4,000 -3.1% $10.65 125,000 06 Nov 2025 By Krieger Charitable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Roger M. Klein is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Price reflects the weighted average sale price for the shares, which were sold in multiple transactions at prices that ranged from $10.65 to $10.66. Upon request, the Reporting Person will provide information regarding the number of shares sold at each price within the range to the Issuer, any security holder of the issuer, or the SEC staff.
F2 Represents securities of the Issuer owned directly by Mr. Klein's Roth Individual Retirement Account ("IRA").
F3 Represents securities of the Issuer owned directly by Krieger Charitable Trust (the "Trust"). Mr. Klein, as sole trustee of the Trust, may be deemed to beneficially own the securities of the Issuer owned directly by the Trust. Mr. Klein disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Mr. Klein is a beneficial owner of the securities of the Issuer reported herein.